# Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

> **NCT05780359** · NA · RECRUITING · sponsor: **Shenzhen Salubris Pharmaceuticals Co., Ltd.** · enrollment: 280 (estimated)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Drug eluting stent
- **DEVICE:** drug coating balloon

## Key facts

- **NCT ID:** NCT05780359
- **Lead sponsor:** Shenzhen Salubris Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-27
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2023-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05780359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05780359, "Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05780359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*